Amplificación del oncogén Her-2/neu en el carcinoma mamario

Cánepa, Mariana; Deninghoff, Valeria; Perazzo, Florencia; Paesani, Fernando; Nieto, Silvana; García, Alejandro; Avagnina, Alejandra; Elsner, Boris.
Medicina (B.Aires) ; 72(1): 88-89, feb. 2012. tab
Artículo en Español | BINACIS | ID: bin-129596

Documentos relacionados

  1. Evaluation of HER2 gene amplification in invasive breast cancer using a dual-color chromogenic in situ hybridization (dual CISH).
  2. [Her-2/neu oncogen amplification in breast cancer].
  3. SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases.
  4. [Assessment of HER2 gene amplification in breast cancer: a comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization].
  5. [Comparison between analysis of HER2 gene and chromosome 17 in breast cancer by dual-probe chromogenic in situ hybridization and fluorescence in situ hybridization].
  6. HER2 gene copy number and breast cancer-specific survival.
  7. Recent advances in aptamer-based sensors for breast cancer diagnosis: special cases for nanomaterial-based VEGF, HER2, and MUC1 aptasensors.
  8. [Dual-color silver-enhanced in-situ hybridization and fluorescence in-situ hybridization for determination of HER2 gene status in gastric carcinoma].
  9. Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancer.
  10. Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer.